<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of the earliest event reported): October 2, 1998
Commission File Number 0-14973
UNICO, INC.
--------------------------------------------------------------------
(Exact name of registrant as specified in charter)
New Mexico 85-0270072
---------------------------------------------------------------------
(State or other jurisdiction of IRS Employer
incorporation or organization) Identification No.
2925 Bayview Drive, Fremont, California 94538
---------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: 510/770-3990
N/A
---------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report.)
<PAGE>
ITEM 5. Other Events
On October 2, 1998, the Registrant issued the press release shown in Item 7.
ITEM 7. Financial Statements, Pro-Forma Financial Information and Exhibits
(c) Exhibit:
99.1 Press release dated October 2, 1998
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
UNICO, INC.
Date: October 2, 1998 BY: /s/ Henry Tang
NAME: HENRY TANG
TITLE: Secretary
EXHIBIT INDEX
Exhibit
Number Description Page
99.1 Unico, Inc. press release (below)
News Release
For more information contact:
Marge Rohr
909/860-0941
FREMONT, Calif. (Business wire) October 2, 1998 Unico, Inc. (Nasdaq: UNRC)
The company was advised by Nasdaq on September 30, 1998 that the securities of
the company should be removed from listing on the Nasdaq Smallcap Market based
on their review of the company's public filings.
The company believes that further discussions with Nasdaq may assist in
clarifying certain issues that have been raised. Accordingly, it intends to
seek procedural remedies and will request a review of the staff's findings.
Unico has been advised by Nasdaq that trading in its securities will continue
during the pendency of the review of the staff's findings.
